aTobacco Control Unit, Catalan Institute of Oncology - WHO Collaborating Centre for Tobacco Control
bTobacco Control Research Group, Epidemiology, Public Health, Cancer Prevention and Palliative Care Programme, Institut d’Investigació Biomèdica de Bellvitge - IDIBELL, L’Hospitalet de Llobregat
cFaculty of Medicine and Health Sciences - Bellvitge Campus, Universitat de Barcelona, Barcelona
dCentro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid
eNursing Research Group, Digestive System, Diagnostics, Pharmacogenetics, Care Support and Clinical Prevention Programme, Institut d’Investigació Biomèdica de Bellvitge - IDIBELL, L’Hospitalet de Llobregat, Spain
fPhilip R. Lee Institute for Health Policy Studies, University of California San Francisco, San Francisco, California, USA
Received 10 December 2021 Accepted 14 March 2022
Correspondence to Esteve Fernández, PhD, Tobacco Control Unit, Catalan Institute of Oncology - WHO Collaborating Centre for Tobacco Control. Av Granvia de L‘Hospitalet, 199-203, 08908 L’Hospitalet de Llobregat, Spain, Tel: +34 93 260 7357; e-mail: [email protected]